Stock RVU RYVU THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Ryvu Therapeutics S.A.

Equities

RVU

PLSELVT00013

Market Closed - Warsaw S.E.
Other stock markets
 09:25:45 10/05/2024 pm IST 		5-day change 1st Jan Change
50.7 PLN +2.42% Intraday chart for Ryvu Therapeutics S.A. -2.12% -11.83%
13/03 Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
06/03 Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ryvu Therapeutics - Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes
AQ
Ryvu Therapeutics Presents Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
AQ
Ryvu Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
AQ
EIB to support Ryvu Therapeutics' discovery, research and development of new cancer treatments with EUR22 million
AQ
Ryvu Therapeutics Announces Promotion of Hendrik Nogai and Vatnak Vat-Ho to the Management Board
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RVU Stock
  4. News Ryvu Therapeutics S.A.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW